Square of the Mahalanobis distance calculated for each sample from both control and pathological class models. (PDF 3122 kb
Table S1. Types of current Parkinson’s disease treatment. Table S2. Sensitivity analysis of correlat...
Table S1. GO biological processes analysis of diferentially expressed genes in blood of Parkinson’s ...
Hierarchical clustering of studies based on the most highly differentially expressed genes in each s...
List of differentially expressed genes between PD patients and controls based on PUMA. Ratios are ca...
List of the 395 variables selected by Ranking-PCA to discriminate between PD patients and controls. ...
List of common genes between A9 DA neurons of the SN in the mouse and differentially expressed trans...
List of common differentially expressed genes between PD patients and controls based on SAM and PUMA...
List of differentially expressed genes between PD patients and controls based on Significance Analys...
List of similar- and anti-similar-to-PD compounds from drug network analysis. Community identifiers,...
Plots of average concordance against sample size for gene expression and biological pathway enrichme...
List of differentially expressed genes between PD patients and controls based on Rank Product analys...
Table S1. Differentially Expressed Gene List. Table S2. Previous differential probes and our analysi...
Detailed information for the entire set of 29 PD cases and 44 controls studied by MS3 proteomics, RN...
Table S1. Cohort statistics with details about age, gender and all other covariates used for differe...
Results for the mRNA abundance comparison between 29 PD and 44 control samples for the 17,580 protei...
Table S1. Types of current Parkinson’s disease treatment. Table S2. Sensitivity analysis of correlat...
Table S1. GO biological processes analysis of diferentially expressed genes in blood of Parkinson’s ...
Hierarchical clustering of studies based on the most highly differentially expressed genes in each s...
List of differentially expressed genes between PD patients and controls based on PUMA. Ratios are ca...
List of the 395 variables selected by Ranking-PCA to discriminate between PD patients and controls. ...
List of common genes between A9 DA neurons of the SN in the mouse and differentially expressed trans...
List of common differentially expressed genes between PD patients and controls based on SAM and PUMA...
List of differentially expressed genes between PD patients and controls based on Significance Analys...
List of similar- and anti-similar-to-PD compounds from drug network analysis. Community identifiers,...
Plots of average concordance against sample size for gene expression and biological pathway enrichme...
List of differentially expressed genes between PD patients and controls based on Rank Product analys...
Table S1. Differentially Expressed Gene List. Table S2. Previous differential probes and our analysi...
Detailed information for the entire set of 29 PD cases and 44 controls studied by MS3 proteomics, RN...
Table S1. Cohort statistics with details about age, gender and all other covariates used for differe...
Results for the mRNA abundance comparison between 29 PD and 44 control samples for the 17,580 protei...
Table S1. Types of current Parkinson’s disease treatment. Table S2. Sensitivity analysis of correlat...
Table S1. GO biological processes analysis of diferentially expressed genes in blood of Parkinson’s ...
Hierarchical clustering of studies based on the most highly differentially expressed genes in each s...